Immunicum AB (publ) Announces Upcoming Investor Events in January
January 22 2019 - 2:30AM
Press Release
22 January 2019
Immunicum AB (publ) Announces Upcoming Investor Events in January
Immunicum AB
(publ; IMMU.ST) announced today that Carlos de Sousa, CEO of
Immunicum, and other members of the management team will present at
upcoming investor conferences in January.
Biomed Investor
Event by Invest Securities
Date: January 22, 2019
Venue: Les Salons Hoche, 9 Avenue Hoche, Paris, France
Redeye Fight Cancer
Seminar
Date: January 22, 2019
Presentation Time: 11.15 am CET
Panel: 11.25 am CET
Venue: Master Samuelsgatan 42, Stockholm, Sweden
Aktiespararna -
Stora Aktiedagen
Date: January 29, 2019
Presentation Time: 8.30 - 9.00 am CET
Panel: "Samtal om cancerbekämpning", 10:50 am CET
Venue: Medicon Village, Scheelevägen 2, Lund, Sweden
For more information, please contact:
Carlos de Sousa, CEO,
Immunicum
Telephone: +46 (0) 31 41 50 52
E-mail: info@immunicum.com
Michaela Gertz, CFO,
Immunicum
Telephone: +46 70 926 17 75
E-mail: ir@immunicum.com
Media Relations
Gretchen Schweitzer and Joanne
Tudorica
Trophic Communications
Telephone: +49 172 861 8540
E-mail: ir@immunicum.com
About Immunicum AB (publ) Immunicum is establishing a unique
immuno-oncology approach through the development of allogeneic,
off-the-shelf cell-based therapies. Our goal is to improve survival
outcomes and quality of life by priming the patient's own immune
system to fight cancer. The company's lead product ilixadencel,
consisting of pro-inflammatory allogeneic dendritic cells, has the
potential to become a backbone component of modern cancer
combination treatments in a variety of solid tumor indications.
Founded and based in Sweden, Immunicum is publicly traded on the
Nasdaq Stockholm. www.immunicum.com
|
20190122_Immunicum_Jan
Conferences_ENG_Final
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Immunicum AB via Globenewswire
Immunomedics (NASDAQ:IMMU)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immunomedics (NASDAQ:IMMU)
Historical Stock Chart
From Apr 2023 to Apr 2024